DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™) ...Middle East

SEOUL, South Korea, June 10, 2024 /PRNewswire/ -- DeepQure, a Seoul based medical device company with a novel, extravascular (laparoscopic approach) solution for renal denervation (RDN), today announced initiation of its Early Feasibility Study (EFS) for the HyperQure™ system following...

Hence then, the article about deepqure receives ide approval from fda for its efs study to treat resistant hypertension with its extravascular renal denervation technology hyperqure was published today ( Monday 10/06/2024 - 08:21 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( DeepQure receives IDE Approval from FDA for its EFS study to treat Resistant Hypertension with its Extravascular Renal Denervation Technology (HyperQure™) )

Also on site :

• Decorated local aviator details his pursuit of recognition for his fellow shadow warriors of the Cold War
• Epstein weaponized in US midterm battles
• Karol G Stunned by Surprise AMAs Win After Accepting International Artist of Excellence: ‘My Life Is Meaningful Because of My Music’